|
2024
|
P/S
|
Pharmaceutical preparations for human use. |
|
|
Invention
|
Combination therapy for prostate cancer.
Provided are methods and compositions, for treating pro... |
|
|
Invention
|
Inhibitors of bruton's tyrosine kinase and methods of their use.
The present disclosure is direc... |
|
|
Invention
|
Malt1 inhibitors. Disclosed are compounds of formula (I), compositions and methods for treating o... |
|
|
Invention
|
Method of treating depression using seltorexant. A method of treating an orexin-2 mediated disord... |
|
|
Invention
|
Esketamine for the treatment of depression.
The present invention provides methods for treating ... |
|
|
Invention
|
Use of fgfr mutant gene panels in identifying cancer patients that will be responsive to treatmen... |
|
|
Invention
|
Treatment of locally advanced or metastatic urothelial carcinoma with erdafinitib. The present in... |
|
|
Invention
|
Monoacylglycerol lipase modulators.
Bridged compounds of Formula (I) and Formula (II), pharmaceu... |
|
|
Invention
|
Delivery of esketamine for the treatment of depression.
The present invention provides devices a... |
|
|
Invention
|
Monoacylglycerol lipase modulators for use in autism spectrum disorders.
The disclosure relates ... |
|
|
Invention
|
Pre-filled syringe with optimized stopper placement.
A pre-filled syringe includes a barrel with... |
|
|
Invention
|
Compounds and uses thereof.
The present invention features compounds useful in the treatment of ... |
|
|
Invention
|
Antibacterial compounds. The present invention relates to the following compounds (I), wherein th... |
|
|
Invention
|
Use of milvexian for treating or preventing adverse cerebrovascular events or adverse cardiovascu... |
|
|
Invention
|
Use of milvexian in the treatment and prevention of thrombotic conditions in patients with atrial... |
|
|
Invention
|
Use of milvexian in the treatment and prevention of thrombotic conditions in patients with cardio... |
|
|
Invention
|
Combination of a menin-ll1 inhibitor, a dna intercalating agent and a pyrimidine analogue to trea... |
|
|
Invention
|
Blood-based assay for detecting tauopathy or amyloidogenic disease.
A method for detecting p217+... |
|
|
Invention
|
Lactam-containing imidazopyridazine il-17 inhibitor compounds. The present application discloses ... |
|
|
Invention
|
Esketamine for use in the treatment of depression. The present invention is directed to methods a... |
|
|
P/S
|
Medical apparatus and instruments for use in surgery;
surgical apparatus and instruments; trocar... |
|
|
P/S
|
Medical apparatus and instruments for use in surgery;
surgical apparatus and instruments. |
|
|
Invention
|
Improved synthetic methods of making substituted pyrimidine intermediates for synthesis of orexin... |
|
|
Invention
|
Interleukin-23 receptor antagonist peptides for use in the treatment of psoriasis. The present in... |
|
|
Invention
|
Fgfr tyrosine kinase inhibitors for the treatment of high-risk non-muscle invasive bladder cancer... |
|
|
Invention
|
Smart pack with oleds. Provided herein is a reusable smart pill dispenser for assisting a user to... |
|
|
Invention
|
Milvexian pharmaceutical compositions. Solid pharmaceutical compositions of a FXIa inhibitor for ... |
|
|
Invention
|
Gene therapy vectors for use in parkinson's disease.
Disclosed herein are recombinant gene thera... |
|
|
Invention
|
Gene therapy vectors for use in parkinson's disease. Disclosed herein are recombinant gene therap... |
|
|
Invention
|
Methods for preparing crystalline peptide inhibitors of interleukin-23 receptor. The present inve... |
|
|
Invention
|
2-(pyridazin-3-yl)-5-(trifluoromethyl)phenols as nlrp3 inhibitors. Provided are compounds for use... |
|
|
Invention
|
Pyrrolo[1,2-d][1,2,4]triazines and pyrazolo[1,5-d] [1,2,4]triazines as nlrp3 inhibitors. Provided... |
|
|
Invention
|
Imidazo[1,2-d][1,2,4]triazines as nlrp3 inhibitors. Provided are compounds for use as inhibitors ... |
|
|
Invention
|
Pyridin-2(1h)-ones and pyrimidin-4(3h)-ones as nlrp3 inhibitors. Provided are compounds for use a... |
|
|
Invention
|
[1,2,4]triazolo[4,3-a]pyridines and [1,2,4]triazolo[4,3-a]pyrazines as nlrp3 inhibitors. Provided... |
|
|
Invention
|
Compositions of peptide inhibitors of interleukin-23 receptor.
The present invention relates to ... |
|
|
Invention
|
Peptide inhibitors of interleukin-23 receptor.
The present disclosure relates to peptide inhibit... |
|
|
Invention
|
Polycyclic peptide inhibitors of interleukin-23 receptor. The present disclosure relates to pepti... |
|
|
Invention
|
Formulations of lipidated peptide inhibitors of interleukin-23 receptor. The present disclosure r... |
|
2023
|
Invention
|
Assessing functional vision of a patient based on patient interaction with a virtual environment.... |
|
2022
|
P/S
|
Human pharmaceutical preparations for the prevention and
treatment of viral diseases, auto-immun... |
|
|
Invention
|
Benzimidazoles as modulators of il-17.
The present application discloses compounds of Formula (I... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer for
human use. |
|
|
Invention
|
Combination therapies for metastatic castration-resistant prostate cancer.
Provided herein are t... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of multiple
sclerosis. |
|
|
P/S
|
Vaccines. |
|
|
Invention
|
Treatment of metastatic castration-resistant prostate cancer with niraparib.
The present inventi... |
|
|
Invention
|
5-oxo-pyrido[2,3-d]pyridazin-6(5h)-yl acetamides.
The invention relates to novel compounds for u... |
|
|
P/S
|
Human pharmaceutical preparations for the prevention and
treatment of oncological diseases and d... |
|
|
Invention
|
Combination therapies.
Disclosed are combinations comprising a therapeutically effective amount ... |
|
|
Invention
|
Substituted spiro derivatives.
The present invention relates to pharmaceutical agents useful for... |
|
|
Invention
|
Digital measurement stacks for characterizing diseases, measuring interventions, or determining o... |
|
|
Invention
|
Tricyclic pyrimidines as cyclin-dependent kinase 7 (cdk7) inhibitors.
The invention relates to p... |
|
|
P/S
|
Pharmaceutical preparations for human purposes. |
|
2021
|
Invention
|
Long-acting formulations.
This invention concerns pharmaceutical compositions for administration... |
|
|
Invention
|
Method of treating a condition using a therapeutically effective dose of 1-(1-oxo-1,2-dihydroisoq... |
